Abstract
A series of prodrugs of 3-mercaptopyruvate (3-MP), the substrate for the enzyme 3-mercaptopyruvate/cyanide sulfurtransferase (3-MPST) that converts cyanide to the nontoxic thiocyanate, which are highly effective cyanide antidotes, have been developed. These prodrugs of 3-MP are unique in being not only orally bioavailable, but may be administered up to an hour prior to cyanide as a prophylactic agent and are both rapid- or slow-acting when given parenterally.
Original language | English (US) |
---|---|
Pages (from-to) | 6462-6464 |
Number of pages | 3 |
Journal | Journal of medicinal chemistry |
Volume | 50 |
Issue number | 26 |
DOIs | |
State | Published - Dec 27 2007 |